The neurofibromatosis market is driven by rising prevalence of genetic disorders affecting nerve tissue growth. Advancements in targeted therapies, supportive care, and diagnostic technologies are enhancing treatment outcomes, supporting market growth through 2028. https://www.databridgemarketresearch.com/reports/global-neurofibromatosis-market